- Home
- JCE vs OLMA Comparison
JCE vs OLMA Comparison
Compare JCE & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCE
- OLMA
- Stock Information
- Founded
- JCE 2007
- OLMA 2006
- Country
- JCE United States
- OLMA United States
- Employees
- JCE N/A
- OLMA N/A
- Industry
- JCE Trusts Except Educational Religious and Charitable
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- JCE Finance
- OLMA Health Care
- Exchange
- JCE Nasdaq
- OLMA Nasdaq
- Market Cap
- JCE 252.4M
- OLMA 289.0M
- IPO Year
- JCE N/A
- OLMA 2020
- Fundamental
- Price
- JCE $14.55
- OLMA $3.33
- Analyst Decision
- JCE
- OLMA Strong Buy
- Analyst Count
- JCE 0
- OLMA 4
- Target Price
- JCE N/A
- OLMA $26.75
- AVG Volume (30 Days)
- JCE 49.7K
- OLMA 910.6K
- Earning Date
- JCE 01-01-0001
- OLMA 03-18-2025
- Dividend Yield
- JCE 9.26%
- OLMA N/A
- EPS Growth
- JCE N/A
- OLMA N/A
- EPS
- JCE N/A
- OLMA N/A
- Revenue
- JCE N/A
- OLMA N/A
- Revenue This Year
- JCE N/A
- OLMA N/A
- Revenue Next Year
- JCE N/A
- OLMA N/A
- P/E Ratio
- JCE N/A
- OLMA N/A
- Revenue Growth
- JCE N/A
- OLMA N/A
- 52 Week Low
- JCE $11.64
- OLMA $3.28
- 52 Week High
- JCE $14.28
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- JCE 39.79
- OLMA 24.82
- Support Level
- JCE $14.17
- OLMA $3.28
- Resistance Level
- JCE $14.90
- OLMA $4.26
- Average True Range (ATR)
- JCE 0.34
- OLMA 0.33
- MACD
- JCE 0.04
- OLMA -0.05
- Stochastic Oscillator
- JCE 59.20
- OLMA 3.40
About JCE Nuveen Core Equity Alpha Fund of Beneficial Interest
Nuveen Core Equity Alpha Fund is a diversified closed-end management investment company. Its investment objective is to provide an attractive level of total return, through long-term capital appreciation and through income and gains. The Fund invests in a portfolio of actively managed large-capitalization U.S. common stocks, using the sub-adviser's proprietary quantitative process designed to provide the potential for long-term outperformance. Additionally, the Fund seeks to reduce the volatility of its returns relative to the returns of the Equity Portfolio over extended periods by writing (selling) index call options and/or call options on custom baskets of securities (the Options Strategy).
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.